CRONOS GROUP INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CRONOS GROUP INC. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $4.00K, a 0.00% change year-over-year.
- CRONOS GROUP INC. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $10.00K.
- CRONOS GROUP INC. stock issued during period, value, stock options exercised for fiscal 2021 was $14.00K, a 55.56% increase from fiscal 2020.
- CRONOS GROUP INC. stock issued during period, value, stock options exercised for fiscal 2020 was $9.00K.
- CRONOS GROUP INC. stock issued during period, value, stock options exercised for fiscal 2019 was -$898.00K, a 306.44% decline from fiscal 2018.
- CRONOS GROUP INC. stock issued during period, value, stock options exercised for fiscal 2018 was $435.00K, a 2.68% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $14.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | $4.00K 10-Q · filed 2022-02-18 | $18.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | $0.00 10-Q/A · filed 2022-02-18 | $18.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-03-31 | $10.00K 10-Q · filed 2021-05-07 | $19.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $9.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $4.00K 10-Q · filed 2022-02-18 | |
| 2020-06-30 | $1.00K 10-Q/A · filed 2022-02-18 | |
| 2019-12-31 | -$54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$898.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$20.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$414.00K 10-Q · filed 2020-08-06 | |
| 2019-03-31 | -$410.00K 10-Q · filed 2020-05-08 | |
| 2018-12-31 | $435.00K 10-K · filed 2021-02-26 | |
| 2017-12-31 | $447.00K 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |